CompletedNot Applicable

Accupressure of P6 to Reduce Nausea During Cesarean Section

United States200 participantsStarted 2021-05-26

Plain-language summary

The purpose of this study is to evaluate if the addition of P6 pressure point stimulation as opposed to sham-point stimulation will decrease intraoperative and postoperative nausea and vomiting (IONV and PONV) for patients undergoing non-emergent cesarean delivery. We hypothesize that the addition of stimulation of the P6 pressure point to our institutional current standard of care (phenylephrine infusion, intravenous fluid bolus, and as needed intraoperative ondansetron) will decrease the occurrence of intraoperative emesis.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥18 years of age * English-speaking * Pregnant patients presenting for scheduled cesarean delivery of a full-term fetus (\>37 weeks' gestation) * Patients scheduled as ERAC * Parturients undergoing spinal anesthesia Exclusion Criteria: * Patients requiring emergent delivery, * Fetal demise * Patients with adhesive allergy/sensitivity * Patients with allergy/sensitivity to nickel, * Patients with inability to consent, * Patients with known abnormal placentation * Patients with pacemakers/defibrillators * Patients with positive COVID-19 tests

What they're measuring

Presence of Intraoperative Vomiting

Timeframe: Intraoperative Period

Presence of Intraoperative Nausea

Timeframe: Intraoperative period

Trial details

NCT IDNCT04799587

SponsorNorthwestern University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-31

Results submitted2025-02-27

View on ClinicalTrials.gov More Pregnancy Related trials